Stock Scorecard



Stock Summary for Medifast Inc (MED) - $13.37 as of 5/16/2025 3:28:00 PM EST

Total Score

14 out of 30

Safety Score

36 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for MED

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for MED

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for MED

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for MED

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for MED (36 out of 100)

Stock Price Rating (Max of 10) 5
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 7
Book Value to Price (Max of 10) 8
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for MED

Medifast Q1 Loss Wider Than Expected, Sales Down 33.8% Y/Y 4/29/2025 12:59:00 PM
Medifast to Report Q1 Earnings: What Investors Should Expect 4/21/2025 1:08:00 PM
Medifast Trades Near 52-Week Low: What's the Best Move Now? 4/15/2025 3:10:00 PM
How Is The Market Feeling About Medifast? - Medifast ( NYSE:MED ) 3/21/2025 3:30:00 PM
MED Q4 Earnings Beat, Revenues Dip Y/Y on Lower Customer Acquisition 2/19/2025 5:05:00 PM
Medifast ( MED ) Q4 Earnings and Revenues Beat Estimates 2/18/2025 10:55:00 PM
MED Focused on GLP-1 Solutions Amid Customer Acquisition Challenges 1/22/2025 2:44:00 PM
Medifast Launches OPTAVIA ASCEND for Weight Loss Management 1/8/2025 11:51:00 AM
Looking Into Medifast's Recent Short Interest - Medifast ( NYSE:MED ) 12/4/2024 8:15:00 PM
Medifast ( MED ) Down 5.8% Since Last Earnings Report: Can It Rebound? 12/4/2024 4:30:00 PM

Financial Details for MED

Company Overview

Ticker MED
Company Name Medifast Inc
Country USA
Description Medifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.
Sector Name MANUFACTURING
Industry Name MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS
Most Recent Quarter 3/31/2025
Next Earnings Date 8/11/2025

Stock Price History

Last Day Price 13.37
Price 4 Years Ago 189.26
Last Day Price Updated 5/16/2025 3:28:00 PM EST
Last Day Volume 340,008
Average Daily Volume 231,654
52-Week High 26.53
52-Week Low 11.57
Last Price to 52 Week Low 15.56%

Valuation Measures

Trailing PE N/A
Industry PE 16.14
Sector PE 44.16
5-Year Average PE -30.97
Free Cash Flow Ratio 1.60
Industry Free Cash Flow Ratio 95.37
Sector Free Cash Flow Ratio 44.59
Current Ratio Most Recent Quarter 3.52
Total Cash Per Share 8.34
Book Value Per Share Most Recent Quarter 20.40
Price to Book Ratio 0.70
Industry Price to Book Ratio 2.21
Sector Price to Book Ratio 4.28
Price to Sales Ratio Twelve Trailing Months 0.28
Industry Price to Sales Ratio Twelve Trailing Months 1.61
Sector Price to Sales Ratio Twelve Trailing Months 2.44
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 10,991,000
Market Capitalization 146,949,670
Institutional Ownership N/A

Dividends

Ex-Dividend Date 9/18/2023
Previous Dividend Amount 0.0000
Current Dividend Amount 1.6500
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 7.26
Forward Annual Dividend Yield 42.88%
5-Year Dividend Payments Count 16
3-Year Average Dividend Yield 6.53%
5-Year Average Dividend Yield 4.52%
1-Year Dividend Growth Rate Percentage 33.33%
3-Year Dividend Growth Rate Percentage 0.30%
5-Year Dividend Growth Rate Percentage 9.93%
All-Time Dividend Growth Rate Percentage 45.24%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -87.20%
Annual Earnings Growth -97.90%
Reported EPS 12 Trailing Months -0.64
Reported EPS Past Year -0.07
Reported EPS Prior Year 2.03
Net Income Twelve Trailing Months -6,997,000
Net Income Past Year 2,091,000
Net Income Prior Year 99,415,000
Quarterly Revenue Growth YOY -33.80%
5-Year Revenue Growth -3.33%
Operating Margin Twelve Trailing Months -1.09%

Balance Sheet

Total Cash Most Recent Quarter 91,717,000
Total Cash Past Year 90,928,000
Total Cash Prior Year 94,440,000
Net Cash Position Most Recent Quarter 64,717,000
Net Cash Position Past Year 90,928,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 27,000,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 0.89
Total Stockholder Equity Past Year 210,109,000
Total Stockholder Equity Prior Year 201,481,000
Total Stockholder Equity Most Recent Quarter 210,959,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 13,465,000
Free Cash Flow Per Share Twelve Trailing Months 1.23
Free Cash Flow Past Year 17,022,000
Free Cash Flow Prior Year 141,174,000

Options

Put/Call Ratio 0.08
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.06
MACD Signal -0.12
20-Day Bollinger Lower Band 11.47
20-Day Bollinger Middle Band 14.34
20-Day Bollinger Upper Band 17.21
Beta 0.98
RSI 46.71
50-Day SMA 17.40
150-Day SMA 63.40
200-Day SMA 93.17

System

Modified 5/17/2025 4:57:14 AM EST